Article
Manifest disease, risk factors for sudden cardiac death, and cardiac events in a large nationwide cohort of predictively tested hypertrophic cardiomyopathy mutation carriers: determining the best cardiological screening strategy.
European heart journal - 1 May 2011
Christiaans Imke, Birnie Erwin, Bonsel Gouke J, Mannens Marcel M A M, Michels Michelle, Majoor-Krakauer Daniëlle, Dooijes Dennis, van Tintelen J Peter, van den Berg Maarten P, Volders Paul G A, Arens Yvonne H, van den Wijngaard Arthur, Atsma Douwe E, Helderman-van den Enden Apollonia T J M, Houweling Arjan C, de Boer Karin, van der Smagt Jasper J, Hauer Richard N W, Marcelis Carlo L M, Timmermans Janneke, van Langen Irene M, Wilde Arthur A M
Abstract excerpt
AIMS: We investigated the presence of a clinical diagnosis of hypertrophic cardiomyopathy (HCM), risk factors for sudden cardiac death (SCD), and cardiac events during follow-up in predictively tested-not known to have a clinical diagnosis of HCM before the DNA test-carriers of a sarcomeric gene mutation and associations with age and gender to determine the best cardiological screening strategy. METHODS AND...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
